{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:55:57Z","timestamp":1762505757978,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4013,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.fertnstert.2011.03.070","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T11:23:03Z","timestamp":1303298583000},"page":"2429.e5-2429.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer"],"prefix":"10.1016","volume":"95","author":[{"given":"Amy","family":"Baigent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Lashen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2011.03.070_bib1","first-page":"1","article-title":"Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jnci\/87.9.645","article-title":"Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies","volume":"87","author":"Rutqvist","year":"1995","journal-title":"J Natl Cancer"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/oxfordjournals.humrep.a138723","article-title":"Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer","volume":"9","author":"Shulman","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib4","first-page":"4454","article-title":"A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three auxiliary lymph nodes","volume":"45","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib5","first-page":"4043","article-title":"Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients","volume":"40","author":"Rose","year":"1980","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib6","unstructured":"Sawka CA, Pritchard KI, Paterson AHG, Sutherland DJA, Thomson DB, Shelley WE, et\u00a0al. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast cancer. Cancer Res 1086;46:3152\u20136."},{"key":"10.1016\/j.fertnstert.2011.03.070_bib7","first-page":"1026","article-title":"Endocrine status of premenopausal node positive breast cancer patients following adjuvant chemotherapy and long term tamoxifen","volume":"48","author":"Ravdin","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib8","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jnci\/83.20.1488","article-title":"Alteration of endocrine parameters in premenopausal women with breast cancer during long term adjuvant tamoxifen therapy","volume":"83","author":"Jordan","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1994.116","article-title":"Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian over-stimulation, cystic formations and fibroid overgrowth","volume":"69","author":"Cohen","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib10","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0015-0282(01)01749-6","article-title":"A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction","volume":"75","author":"Boostanfar","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02109916","article-title":"Comparison between tamoxifen and clomephine therapy in women with anovulation","volume":"227","author":"Gerhard","year":"1979","journal-title":"Arch Gynecol"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers","volume":"333","author":"Fornander","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/gyno.1998.5201","article-title":"Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients","volume":"72","author":"Cohen","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9378(96)70386-1","article-title":"Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer","volume":"174","author":"Shushan","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib15","first-page":"299","article-title":"Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman: a case report","volume":"35","author":"Jolles","year":"1990","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI109475","article-title":"Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women","volume":"64","author":"Sherman","year":"1979","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejogrb.2004.09.006","article-title":"Ovarian cysts in tamoxifen-treated women with breast cancer","volume":"120","author":"Inal","year":"2004","journal-title":"Eur J Obstet Gyn R B"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib18","first-page":"607","article-title":"Ovarian cyst formation in patients using tamoxifen for breast cancer","volume":"35","author":"Metindir","year":"2005","journal-title":"Jpn J\u00a0Clin Oncol"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib19","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/sj.bjc.6690280","article-title":"Ovarian cysts in women receiving tamoxifen for breast cancer","volume":"79","author":"Mourits","year":"1999","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","article-title":"Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial","volume":"343","author":"Kedar","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0301-2115(00)00474-7","article-title":"Successful management of an ovarian enlargement resembling ovarian hyperstimulation in a premenopausal breast cancer patient receiving tamoxifen with co-treatment of GnRH-agonist","volume":"97","author":"Turan","year":"2001","journal-title":"Eur J Obstet Gyn R B"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/09513590400015526","article-title":"Management of anovulatory infertility associated with polycystic ovary syndrome: tamoxifen citrate an effective alternative compound to clomiphene citrate","volume":"19","author":"Nardo","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(97)81373-8","article-title":"Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome","volume":"67","author":"Benadiva","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0015-0282(16)47173-6","article-title":"Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins","volume":"40","author":"Haning","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0015-0282(00)00491-X","article-title":"The ovarian hyperstimulation syndrome","volume":"73","author":"Whelan","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0015-0282(16)59484-9","article-title":"Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome","volume":"48","author":"J\u00e4ger","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib27","first-page":"79","article-title":"CA-125 and ovarian hyperstimulation","volume":"23","author":"Scarpellini","year":"1992","journal-title":"Acta Eur Fertil"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0020-7292(95)02590-1","article-title":"Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer","volume":"52","author":"Shushan","year":"1996","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib29","series-title":"A textbook of in-vitro fertilization and assisted reproduction","first-page":"131","article-title":"Classification, pathophysiology and management of ovarian hyperstimulation syndrome","author":"Rizk","year":"1999"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib30","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/oxfordjournals.humrep.a138260","article-title":"The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features","volume":"8","author":"Delvigne","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0015-0282(99)00090-4","article-title":"Prospective study of the clinical and\u00a0laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization","volume":"71","author":"Enskog","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000292666","article-title":"A follicular cyst during tamoxifen therapy in a premenopausal breast cancer woman","volume":"35","author":"Terada","year":"1993","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2011.03.070_bib35","first-page":"5589","article-title":"Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780","volume":"53","author":"Hung","year":"1993","journal-title":"Cancer Res"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028211005000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028211005000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:54:43Z","timestamp":1758009283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028211005000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0015028211005000"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2011.03.070","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2011.03.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}